A real-world retrospective study to assess the effectiveness and safety profile of siponimod in Chinese patients with relapsing forms of multiple sclerosis
Authors
Zheng Li (ORCID: https://orcid.org/0000-0003-1410-5615)
Anne Lin (ORCID: https://orcid.org/0000-0003-0200-6361)
Y Zhang (ORCID: https://orcid.org/0000-0002-1489-3044)
Min Cai (ORCID: https://orcid.org/0000-0001-6628-0277)
Lei Liu (ORCID: https://orcid.org/0000-0002-7069-1383)
Ming Zhou (ORCID: https://orcid.org/0000-0003-2545-1134)
Hongbo Liu
Yan Xu (ORCID: https://orcid.org/0000-0002-8469-6476)
Institutions
Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
Peking Union Medical College Hospital (CN)
IQVIA (United Kingdom) (GB)
Novartis (China) (CN)
First Affiliated Hospital of Zhengzhou University (CN)
A real-world retrospective study to assess the effectiveness and safety profile of siponimod in Chinese patients with relapsing forms of multiple sclerosis
Zheng Li, Anne Lin, Y Zhang, Min Cai et al.
Journal
BMC Neurology
Topics
Multiple Sclerosis Research Studies
article
A real-world retrospective study to assess the effectiveness and safety profile of siponimod in Chinese patients with relapsing forms of multiple sclerosis
Zheng Li, Anne Lin, Y Zhang, Min Cai, Lei Liu, Ming Zhou, Hongbo Liu, Yan Xu
article en
Abstract
No abstract available for this paper.
Publication Tag
BMC NeurologyVol. 25(1)
Institutions
Chinese Academy of Medical Sciences & Peking Union Medical College (CN), Peking Union Medical College Hospital (CN), IQVIA (United Kingdom) (GB), Novartis (China) (CN), First Affiliated Hospital of Zhengzhou University (CN)